Suiza - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

axapharm ag - omeprazolum - capsule - omeprazolum 10.00 mg, sacchari sphaerae corresp. saccharum 5.36-6.13 mg et maydis amylum, magnesii hydroxidum, maydis amylum, dinatrii phosphas, hypromellosum, natrii laurilsulfas, mannitolum, carboxymethylamylum natricum a, talcum, e 171, macrogolum 6000, polysorbatum 80, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, kapselhülle: e 133, e 172 (flavum), gelatina, e 171 pro capsula corresp. natrium 0.347 mg. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

Suiza - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

axapharm ag - omeprazolum - capsule - omeprazolum 20.00 mg, sacchari sphaerae corresp. saccharum 10.72-12.26 mg et maydis amylum, magnesii hydroxidum, maydis amylum, dinatrii phosphas, hypromellosum, natrii laurilsulfas, mannitolum, carboxymethylamylum natricum a, talcum, e 171, macrogolum 6000, talcum, polysorbatum 80, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, kapselhülle: e 132, gelatina, e 171 pro capsula corresp. natrium 0.694 mg. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

Suiza - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

axapharm ag - omeprazolum - capsule - omeprazolum 40.00 mg, sacchari sphaerae corresp. saccharum 21.44-24.52 mg et maydis amylum, magnesii hydroxidum, maydis amylum, dinatrii phosphas, hypromellosum, natrii laurilsulfas, mannitolum, carboxymethylamylum natricum a, talcum, e 171, macrogolum 6000, polysorbatum 80, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, kapselhülle: e 172 (nigrum), gelatina, e 171 pro capsula corresp. natrium 1.388 mg. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

Suiza - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - topiramatum - lactab - topiramatum 300 mg, lactosum monohydricum 133.5 mg, per amylum pregelificatum, cellulosum microcristallinum, carboxymethylamylum natricum un corrisp. sodio max. 0,8 mg, silice colloidalis anhydrica, magnesio stearas, Überzug: polydextrosum, hypromellosum, e 171, macrogolum 4000, pro compresso haze. - farmaco antiepilettico, migräneprophylaxe - synthetika

Suiza - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - topiramatum - lactab - topiramatum 400 mg, lactosum monohydricum 178 mg, per amylum pregelificatum, cellulosum microcristallinum, carboxymethylamylum natricum un corrisp. sodio max. 1.0 mg, silice colloidalis anhydrica, magnesio stearas, Überzug: polydextrosum, hypromellosum, e 171, macrogolum 4000, pro compresso haze. - farmaco antiepilettico, migräneprophylaxe - synthetika

Suiza - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - pantoprazolum - gastroresistenti compresse rivestite con film - pantoprazolum 20 mg ordine pantoprazolum natricum sesquihydricum, mannitolum, natrii carbonas, carboxymethylamylum natricum un copolymerum methacrylatis butylati formano la dieta base, come il calcio stearas, Überzug: acidi methacrylici e ethylis acrylatis polymerisatum 1:1, propylenglycolum, e 172 (giallo), e 171, talco, hypromellosum, macrogolum 400, natrii laurilsulfas, per compresso haze corrisp. sodio max. 4.34 mg. - trattamento a breve termine di refluxsymptomen per adulti - synthetika

Suiza - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

acino pharma ag - pantoprazolum - liofilizzato - praeparatio cryodesiccata: pantoprazolum 40 mg ut pantoprazolum natricum, dinatrii edetas, natrii hydroxidum, pro vitro corresp. natrium 2.68 mg. - inibitori della pompa protonica - synthetika

Unión Europea - italiano - EMA (European Medicines Agency)

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - agenti antineoplastici - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase.  chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib.  ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib.  newly diagnosed ph+ all in combination with chemotherapy.

Suiza - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

galepharm ag - prednisonum - compresse - prednisonum 5 mg, lactosum monohydricum 77.2 mg, cellulosum microcristallinum, carmellosum natricum solo tenuti insieme corrisp. sodio max. 0,3 mg, povidonum k 30, magnesio stearas, pro compresso. - glukokortikosteroid-therapie - synthetika

Suiza - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

galepharm ag - prednisonum - compresse - prednisonum 20 mg, lactosum monohydricum 138 mg, cellulosum microcristallinum, carmellosum natricum solo tenuti insieme corrisp. sodio max. 0.5 mg, povidonum k 30, magnesio stearas, pro compresso. - glukokortikosteroid-therapie - synthetika